GENMAB - Begivenhedskalender
-
Genmab - Begivenhedskalender for pipelinen
'
Q3/Q4 2018Fase
III-data (MAIA) med Darzalex + Rd i nydiagnosticeret knoglemarvskræft- oktober 2018
Johnson & Johnson (Janssen) Q3 2018 - Darzalex salg
- oktober 2018
Symphony Health Solutions - Darzalex-salgstal for september
Q3/Q4 2018
Fase
III-data (Cassiopeia) med Darzalex + Vtd i nydiagnosticeret knoglemarvskræftQ3/Q4 2018
Annoncere studie i andre cancer-former for tisotumab vedotin
Q3/Q4 2018
Yderligere data for tisotumab vedotin
- november
Genmab Q3 2018
- november
Symphony Health Solutions - Darzalex-salgstal for oktober
ASH kræftkonference i San Diego
Symphony Health Solutions - Darzalex-salgstal for november
2019
Fase III-data for Arzerra (ofatumumab) i attakvis multipel sklerose (RRMS)
https://markets.sydbank.dk/PublicationsWebHandler/Default.aspx?ID=0042061-056801
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind